UroToday

ASTRO 2025: EPIC-26 Longitudinal Analyses of Prostatic Urethral Lift Implant with Stereotactic Ablative Body Radiotherapy for Men with Prostate Cancer and BPH

The 2025 ASTRO annual meeting featured a prostate cancer radiation toxicity session and a presentation by Dr. Young Suk Kwon discussing an EPIC-26 longitudinal analyses of prostatic urethral lift ...
Medscape

Phosphorylated EGFR as a Predictive Marker for Indolent Prostate Cancer

Hammarsten and colleagues examined formalin-fixed tissue specimens from 259 patients with prostate cancer that were obtained during transurethral prostate resection and analyzed for the presence of ...
ascopubs.org

Oncological outcomes with wide resection in robot-assisted radical prostatectomy as primary treatment for very high-risk prostate cancer.

Planned interim analysis of perioperative safety of fluzoparib combined with abiraterone in the neoadjuvant treatment of locoregional high-risk prostate cancer: Results from multicenter, phase 2 ...
Medscape

Virus Found in 27% of Prostate Cancers, Linked to More Aggressive Tumors

September 8, 2009 — A type of virus known to cause leukemia and sarcomas in animals has been found in malignant human prostate cancer cells, and this infectious agent might be responsible prostate ...
ascopubs.org

Randomized PROSTATE-IQ trial to reduce ADT treatment burden for patients with biochemical recurrence after prostatectomy.

CLARIFY: Positron emission tomography using 64Cu-SAR-bisPSMA in patients with high-risk prostate cancer prior to radical prostatectomy (a phase 3 diagnostic study). Vibostolimab coformulated with ...